Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)

Hong Kong · Delayed Price · Currency is HKD

6.15

+0.27 (4.59%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Research and Development of New Drugs	155.71M	63.52M	95.75M	152.81M	486.29M
Research and Development of New Drugs Growth	145.13%	-33.66%	-37.34%	-68.58%	-
Total	155.71M	63.52M	95.75M	152.81M	486.29M
Total Growth	145.13%	-33.66%	-37.34%	-68.58%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
The People's Republic of China (The PRC)	155.71M	63.52M	95.75M	152.81M	486.29M
The People's Republic of China (The PRC) Growth	145.13%	-33.66%	-37.34%	-68.58%	-
Total	155.71M	63.52M	95.75M	152.81M	486.29M
Total Growth	145.13%	-33.66%	-37.34%	-68.58%	-

Source: S&P Global Market Intelligence.